Medical Condition News

RSS

KLOX receives CE mark approval in Europe for non-invasive acne vulgaris treatment

KLOX Technologies Inc. is pleased to announce that it has received CE mark approval in Europe for its topical photo-converter gel as a Class IIa Medical Device for the treatment of acne vulgaris, including all severities. The gel is part of KLOX's LumiCleanse System, a first-in-class innovative, non-invasive acne vulgaris treatment with a clinically-proven superior safety and efficacy profile. The LumiCleanseTM System was previously approved for the treatment of all severities of acne vulgaris in Canada in September of this year.

19 Nov 2013

$New trial assess effects on hip fracture, colorectal cancer incidence in postmenopausal women$

New trial assess effects on hip fracture, colorectal cancer incidence in postmenopausal women

New results are in from the Women's Health Initiative (WHI) Calcium plus Vitamin D Supplementation Trial. These findings assess the effects on hip fracture and colorectal cancer incidence among 30,000 postmenopausal women nearly five years after the seven-year period of calcium plus vitamin D supplementation ended.

19 Nov 2013

GM-CSF therapy does not improve treadmill walking time in patients with peripheral artery disease

Joseph Poole, M.D., Ph.D., of the Emory University School of Medicine, Atlanta, and colleagues studied whether therapy with granulocyte-macrophage colony stimulating factor (GM-CSF), an agent that functions as a white blood cell growth factor, would improve walking performance in patients with symptomatic peripheral artery disease (a form of vascular disease in which there is partial or total blockage of an artery, usually one leading to a leg or arm).

19 Nov 2013

AGA, Covidien partner to improve lives of people struggling with digestive diseases

The American Gastroenterological Association Institute announced today that Covidien, a leading global provider of health-care products, recently agreed to expand its corporate grant to the AGA Institute.

19 Nov 2013

Study finds patients treated with varespladib drug more likely to experience cardiovascular events

Patients with acute coronary syndrome who were treated with the experimental drug varespladib were more likely to experience additional cardiovascular events - including sudden death, heart attack and stroke - than those treated with placebo, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research).

19 Nov 2013

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

A blood cell growth factor can boost the effects of exercise in improving mobility for patients with peripheral artery disease, a clinical study has shown.

19 Nov 2013

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

Curie-Cancer, the body responsible for developing Institut Curie's industry partnership activity, today announces two three-year partnership agreements with Meiogenix, a French SME. Meiogenix develops SpiX technology under license from Institut Curie and Institut National de la Recherche Agronomique.

19 Nov 2013

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Pioneering research by the Optoelectronics Research Centre that could transform the care of cancer patients or people with infections in their own homes has received a significant grant from the Engineering and Physical Sciences Research Council.

19 Nov 2013

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

The Boston Scientific Corporation Vercise Deep Brain Stimulation System has received CE Mark approval for the treatment of intractable primary and secondary dystonia, a neurological movement disorder characterized by involuntary muscle contractions.

19 Nov 2013

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

Atopix Therapeutics Ltd, a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the recruitment of the first patient in a six month Phase 2 clinical trial of its lead compound OC459 in moderate-to-severe atopic dermatitis (eczema).

19 Nov 2013

New technology to give voice to people with severe speech impairment

The first speech recognition aid to give a voice to people with severe speech impairment is the flagship technology on display today [19 November] at the launch of the University of Sheffield’s new Centre for Assistive Technology and Connected Healthcare.

19 Nov 2013

Long-term use of PDE3 inhibitors can lead to increased risk for sudden cardiac death

Drugs known as PDE3 inhibitors save many lives by helping failing hearts do a better job of pumping blood. But those same medications come with a sometimes deadly cost when taken for long periods: an increased risk for sudden cardiac death.

19 Nov 2013

Annual rates of CPR training vary widely across the U.S.

Annual rates of CPR training in the United States are low and vary widely across the country, but the communities most in need of training are the least likely to be trained, according to a new study from the Duke Clinical Research Institute.

19 Nov 2013

Study confirms therapeutic potential of inhibiting Aurora-A in cancer treatment

Aurora-A is a protein involved in the cell division process that is highly expressed or synthesised in a large number of human cancers, especially in those associated with a bad prognosis. Several pharmaceutical companies have recently developed these protein inhibitors, although the therapeutic and physiological effects that blocking Aurora-A might have on adult tissues are still unknown.

19 Nov 2013

Eating tree nuts reduces risk of pancreatic cancer, shows women’s health study

According to a long-term women's health study recently published, women in the study who ate a one-ounce serving of tree nuts two or more times a week had a reduced risk of pancreatic cancer compared to those studied who did not include nuts in their diet.

19 Nov 2013

New $3.4 million NIH grant to fund artificial pancreas projects

A high-tech project to turn an ordinary smart phone into an artificial pancreas that could transform the lives of people with type 1 diabetes has received a $3.4 million grant from the National Institutes of Health.

19 Nov 2013

Researchers discover association between RDW levels and depression in heart disease patients

Researchers at the Intermountain Medical Center Heart Institute have discovered a link between elevated red cell distribution width levels and depression in patients being treated for heart disease.

19 Nov 2013

Philipp E. Scherer honored with 15th Naomi Berrie Award for Outstanding Research in Diabetes

Columbia University Medical Center has honored Philipp E. Scherer, PhD, with the 15th Naomi Berrie Award for Outstanding Research in Diabetes, for his work that helped usher in a new understanding of fat and its role in diabetes and other metabolic diseases. His discovery of adiponectin, a hormone produced by fat, helped transform the scientific concept of fat as an inert storage depot to one of it as an endocrine "organ" that exerts control over the brain, muscles, and other organs. The award, given annually by CUMC's Naomi Berrie Diabetes Center, is Columbia's top honor for excellence in diabetes research.

19 Nov 2013

Study: Use of bone marrow mononuclear stem cells does not improve heart function

New data reported by the Cardiovascular Cell Therapy Research Network (CCTRN) at the 2013 Scientific Sessions of the American Heart Association in Dallas showed that the use of bone marrow mononuclear stem cells (BMCs) did not improve heart function significantly more at one year than at six months.

19 Nov 2013

Study examines two surgical approaches for treatment of severe ischemic mitral regurgitation

The Cardiothoracic Surgical Trials Network, whose Data and Clinical Coordinating Center is at Icahn School of Medicine at Mount Sinai, is reporting for the first time evidence on whether or not there is any significant difference between the two current surgical approaches to treat patients with severe ischemic mitral regurgitation -- mitral valve repair and mitral valve replacement.

19 Nov 2013

Medical Condition News

KLOX receives CE mark approval in Europe for non-invasive acne vulgaris treatment

New trial assess effects on hip fracture, colorectal cancer incidence in postmenopausal women

GM-CSF therapy does not improve treadmill walking time in patients with peripheral artery disease

AGA, Covidien partner to improve lives of people struggling with digestive diseases

Study finds patients treated with varespladib drug more likely to experience cardiovascular events

Study: Blood cell growth factor improves effects of exercise in patients with peripheral artery disease

Curie-Cancer inks partnership agreements with Meiogenix to develop SpiX technology

ORC to develop paper-based sensors to detect biomarkers in cancer patients

Boston Scientific gets CE Mark approval for Vercise Deep Brain Stimulation System

Atopix recruits first patient in OC459 Phase 2 trial for treatment of atopic dermatitis

New technology to give voice to people with severe speech impairment

Long-term use of PDE3 inhibitors can lead to increased risk for sudden cardiac death

Annual rates of CPR training vary widely across the U.S.

Study confirms therapeutic potential of inhibiting Aurora-A in cancer treatment

Eating tree nuts reduces risk of pancreatic cancer, shows women’s health study

New $3.4 million NIH grant to fund artificial pancreas projects

Researchers discover association between RDW levels and depression in heart disease patients

Philipp E. Scherer honored with 15th Naomi Berrie Award for Outstanding Research in Diabetes

Study: Use of bone marrow mononuclear stem cells does not improve heart function

Study examines two surgical approaches for treatment of severe ischemic mitral regurgitation

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News